Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66M Sell
13,239
-439
-3% -$157K 0.54% 50
2025
Q4
$4.48M Buy
13,678
+142
+1% +$45K 0.5% 48
2025
Q3
$3.82M Sell
13,536
-155
-1% -$45K 0.45% 52
2025
Q2
$3.82M Sell
13,691
-208
-1% -$58.9K 0.48% 50
2025
Q1
$4.33M Sell
13,899
-243
-2% -$71.8K 0.6% 45
2024
Q4
$3.69M Sell
14,142
-338
-2% -$100K 0.49% 51
2024
Q3
$4.67M Sell
14,480
-342
-2% -$112K 0.62% 44
2024
Q2
$4.63M Sell
14,822
-48
-0.3% -$14.1K 0.66% 43
2024
Q1
$4.23M Sell
14,870
-456
-3% -$133K 0.61% 47
2023
Q4
$4.41M Sell
15,326
-891
-5% -$243K 0.7% 37
2023
Q3
$4.36M Sell
16,217
-864
-5% -$216K 0.78% 35
2023
Q2
$3.79M Sell
17,081
-394
-2% -$91.4K 0.64% 40
2023
Q1
$4.22M Sell
17,475
-724
-4% -$178K 0.77% 31
2022
Q4
$4.78M Sell
18,199
-344
-2% -$92.2K 0.92% 27
2022
Q3
$4.18M Sell
18,543
-876
-5% -$212K 0.9% 27
2022
Q2
$4.72M Sell
19,419
-777
-4% -$190K 0.87% 28
2022
Q1
$4.88M Buy
20,196
+539
+3% +$124K 0.78% 36
2021
Q4
$4.42M Buy
19,657
+5
+0% +$1.05K 0.69% 44
2021
Q3
$4.18M Buy
19,652
+651
+3% +$150K 0.72% 39
2021
Q2
$4.63M Buy
19,001
+487
+3% +$120K 0.81% 32
2021
Q1
$4.61M Buy
18,514
+177
+1% +$42.2K 0.86% 28
2020
Q4
$4.22M Buy
18,337
+1,107
+6% +$255K 0.91% 25
2020
Q3
$4.38M Buy
17,230
+610
+4% +$151K 1.14% 23
2020
Q2
$3.92M Buy
16,620
+480
+3% +$110K 1.19% 21
2020
Q1
$3.27M Buy
16,140
+1,059
+7% +$231K 1.31% 19
2019
Q4
$3.64M Sell
15,081
-1,809
-11% -$399K 1.23% 23
2019
Q3
$3.27M Buy
16,890
+2,395
+17% +$460K 1.23% 22
2019
Q2
$2.67M Buy
14,495
+598
+4% +$107K 1.04% 30
2019
Q1
$2.64M Sell
13,897
-1,711
-11% -$327K 1.11% 27
2018
Q4
$3.04M Buy
15,608
+1,494
+11% +$291K 1.35% 18
2018
Q3
$2.93M Sell
14,114
-1,044
-7% -$206K 1.08% 27
2018
Q2
$2.8M Sell
15,158
-29
-0.2% -$5.13K 1.09% 28
2018
Q1
$2.59M Buy
15,187
+266
+2% +$48.8K 1.09% 30
2017
Q4
$2.6M Buy
14,921
+366
+3% +$64.8K 1.08% 29
2017
Q3
$2.71M Sell
14,555
-217
-1% -$38.4K 1.23% 22
2017
Q2
$2.54M Buy
14,772
+66
+0.4% +$10.7K 1.18% 25
2017
Q1
$2.41M Buy
14,706
+352
+2% +$58.5K 1.17% 24
2016
Q4
$2.1M Buy
14,354
+662
+5% +$99.6K 1.06% 27
2016
Q3
$2.28M Buy
13,692
+913
+7% +$154K 1.26% 24
2016
Q2
$1.94M Buy
12,779
+292
+2% +$45.4K 1.12% 28
2016
Q1
$1.87M Buy
12,487
+1,144
+10% +$170K 1.12% 27
2015
Q4
$1.84M Buy
11,343
+126
+1% +$19.8K 1.17% 25
2015
Q3
$1.55M Buy
11,217
+587
+6% +$92.5K 1.07% 30
2015
Q2
$1.63M Sell
10,630
-40
-0.4% -$6.41K 1.04% 30
2015
Q1
$1.71M Buy
+10,670
New +$1.68M 1.06% 29

Other funds holding AMGN

River Wealth Advisors's AMGN Position: Q1 2026 in Review

River Wealth Advisors reduced its Amgen (AMGN) stake by 3.2% in Q1 2026, selling an estimated $157K and leaving 13,239 shares worth $4.66M. The position accounts for 0.54% of the portfolio, ranked #50.

River Wealth Advisors first reported a position in AMGN in Q1 2015 and has held it in 45 quarters since. The position peaked at $4.88M in Q1 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • River Wealth Advisors held 13,239 shares of Amgen worth $4.66M as of Q1 2026.
  • River Wealth Advisors sold 439 Amgen shares in Q1 2026, an estimated $157K.
  • Amgen made up 0.54% of River Wealth Advisors's portfolio in Q1 2026, its #50 holding.
  • River Wealth Advisors first reported a position in Amgen in Q1 2015 and has held it in 45 quarters since.
  • River Wealth Advisors's Amgen position peaked at $4.88M in Q1 2022.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on River Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.